1. Bowdon BJ, Waud WR, Wheeler GP, Hain R, Dansby L, Temple C Jr (1987) Comparison of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines) with several other inhibitors of mitosis. Cancer Res 47: 1621
2. Hill BT, Whelan RDH, Bellamy AS (1984) Identification of differential drug responses and mechanism of resistance in vincristine-resistant cell lines developed either by exposure to the drug or to fractionated radiation. Cancer Treat Rev 11 [Suppl A]: 73
3. Horton JK, Houghton PJ, Houghton JA (1987) Reciprocal cross-resistance in human rhabdomyosarcomas selected in vivo for primary resistance to vincristine andl-phenylalanine mustard. Cancer Res 47: 6288
4. Lloyd HH (1977) Application of tumor models toward the design of treatment schedules for cancer chemotherapy: In Drewinko B, Humphrey RM (eds) Growth kinetics and biochemical regulation of normal and malignant cells. Williams & Wilkins, Baltimore, p 455
5. Schabel FM Jr, Griswold DP Jr, Laster WR Jr, Corbett TH, Lloyd HH (1977) Quantitative evaluation of anticancer agent activity in experimental animals. Pharmacol Ther [A] 1: 411